JBT Marel Q3 Adjusted EBITDA Hits Record as Revenue Outlook Falls

JBT Marel (NYSE: JBTM) reported record quarterly adjusted EBITDA and adjusted EBITDA margin for the third quarter of 2026 despite a slight decline in revenue, as cost controls, acquisition synergies, pricing and business mix offset weaker book-and-ship activity in its Prepared Food and Beverage Solutions segment. The company lowered its full-year revenue outlook but increased adjusted EPS guidance and the midpoint of its adjusted EBITDA margin forecast.

Consolidated revenue declined 1% year over year to $994 million from $1.00 billion. Revenue was about $25 million below the midpoint of the company’s guidance, primarily because of lower book-and-ship sales in the consumer packaged goods end market within Prepared Food and Beverage Solutions.

Adjusted EBITDA increased 5% to a quarterly record of $179 million, while adjusted EBITDA margin rose 90 basis points to 18.0%. JBT Marel said lower operating expenses, including cost controls and seasonal spending patterns, more than offset an approximately $6 million adjusted EBITDA impact from lower volume. Adjusted EBITDA finished $3 million above the implied guidance midpoint.

Adjusted diluted EPS increased 13% to $2.19 from $1.94, supported by operating execution and lower interest expense. Foreign-exchange movements had a minimal effect on the quarter’s results.

Protein growth offsets weaker prepared food and beverage sales

Protein Solutions revenue rose 6% to $469 million, driven by the conversion of a strong poultry backlog into sales. Segment adjusted EBITDA increased 12% to $105 million, and the margin expanded to 22.4% from 21.3%, reflecting volume leverage, cost synergies and pricing.

Prepared Food and Beverage Solutions revenue fell 6% to $525 million. The decline was attributed to lower CPG-related book-and-ship volume in the Diversified Food and Health business. Segment adjusted EBITDA slipped 1% to $101 million, but its margin increased 90 basis points to 19.2%.

The company said restructuring benefits in warehouse automation, favorable segment mix, cost synergies and pricing more than offset the margin pressure from lower volume leverage in the segment.

Consolidated orders increased 3% to $976 million and were spread across ready meals, pork, prepared foods and secondary poultry applications. Quarterly book-to-bill was just below 1.0, while the ratio for the trailing four quarters was 1.05. Backlog stood at $1.52 billion at the end of the quarter.

Recurring revenue totaled $502 million, compared with $492 million of non-recurring revenue, maintaining a roughly 50% recurring mix. JBT Marel said its installed equipment base supports demand for service and high-wear replacement parts needed to keep high-volume systems operating.

Revenue forecast reduced as adjusted EPS outlook rises

JBT Marel now expects full-year 2026 revenue of $3.95 billion to $4.00 billion, compared with its previous range of $3.99 billion to $4.07 billion. The revision reflects the third-quarter shortfall in book-and-ship activity and updated fourth-quarter expectations for Diversified Food and Health.

The company expects an adjusted EBITDA margin of 17.25% to 17.50%, narrowing the prior 17.0% to 17.5% range and increasing its midpoint. Management attributed the change to operating execution and disciplined cost management.

Adjusted EPS is projected at $8.10 to $8.40, up from the previous $7.85 to $8.35 forecast, reflecting lower expected interest expense, taxes and share count. GAAP diluted EPS is expected to range from $4.30 to $4.60, while the net income margin is forecast at 5.6% to 6.0%.

At the midpoint of the revenue outlook, consolidated sales would grow approximately 5% year over year, including an estimated 1.5% benefit from foreign-currency translation. Full-year capital expenditures are expected to be $100 million to $110 million, with total depreciation and amortization of approximately $261 million.

Cash flow supports expanded repurchase program

Third-quarter free cash flow, a non-GAAP measure, increased to $73 million from $57 million, equivalent to 41% of adjusted EBITDA. Trailing four-quarter free cash flow was $339 million, representing 52% of adjusted EBITDA.

JBT Marel repurchased approximately 800,000 shares for about $94 million during the quarter while keeping its leverage ratio below 2.5 times. On October 30, its board added $500 million to the existing repurchase authorization, bringing the total program to $700 million. Management said future repurchases would be balanced against its desired long-term leverage range of 2.0 to 2.5 times.

The company remains focused on generating approximately $150 million of realized annual cost-synergy savings by 2028 and reaching a 20% adjusted EBITDA margin that year. It expects annual run-rate savings of about $85 million exiting 2026 and approximately $150 million exiting 2027. Changes in the trade and inflation environment have led JBT Marel to supplement some supply-chain savings with faster facility consolidation.

Five manufacturing, distribution and service sites had been closed as of September 30. Projects planned for 2026 and 2027 are expected to reduce manufacturing and distribution space by approximately 1.1 million square feet and office space by about 200,000 square feet.

Execution remains subject to integration and restructuring risks, including the combination of the legacy JBT and Marel operations and the timing of facility transfers. The company also identified inflation, tariffs and trade rules, currency and interest-rate fluctuations, sales-cycle variability, supply-chain constraints, indebtedness and its ability to remediate material weaknesses related to Marel’s financial statements among factors that could cause actual results to differ from its expectations.